Leap Therapeutics, Inc. (LPTX) Social Stream



Leap Therapeutics, Inc. (LPTX): $2.66

0.12 (-4.32%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add LPTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#199 of 365

in industry

LEAP THERAPEUTICS INC (LPTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LPTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-18 5 $6 $4 $4.8 $3.26 47.24%
2022-01-21 5 $6 $4 $5 $3.26 53.37%
2022-03-11 3 $6 $4 $5 $3.26 53.37%
2022-05-16 4 $6 $4 $5 $3.26 53.37%
2022-05-27 4 $6 $4 $4.5 $3.26 38.04%
2022-07-13 4 $6 $3 $4.25 $3.26 30.37%
2022-08-15 4 $6 $3.5 $4.375 $3.26 34.2%
2022-11-16 3 $4 $2.5 $3.5 $3.26 7.36%
2023-01-18 4 $3 $2.5 $2.666 $3.26 -18.22%
2023-01-27 4 $3 $2.5 $2.75 $3.26 -15.64%
2023-03-27 4 $3 $2 $2.7 $3.26 -17.18%
2023-05-16 4 $3 $2 $2.5 $3.26 -23.31%
2023-06-30 4 $30 $17 $24.4 $3.26 648.47%
2023-07-13 4 $30 $18.5 $24.7 $3.26 657.67%
2023-08-14 5 $30 $18.5 $24.7 $3.26 657.67%
2023-11-14 5 $21 $7 $15.3 $3.26 369.33%
2023-11-20 5 $21 $7 $13.7 $3.26 320.25%

The Trend in the Analyst Price Target


Over the past 12 months, LPTX's average price target has gone up $10.2.

Over the past 44 weeks, LPTX's average upside potential has been 875.65%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 4 3 2.5 2.75 0.641 329.02%
2023-03-27 4 3 2.5 2.80 0.290 865.52%
2023-04-05 4 3 2.0 2.50 0.330 657.58%
2023-11-14 5 21 7.0 15.30 1.560 880.77%
2023-11-14 5 25 7.0 18.10 1.560 1060.26%

LPTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 4 1 0 0 0 5

The Trend in the Broker Recommendations


Over the past 153 days, LPTX's average broker recommendation rating improved by 0.05.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how LEAP THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is higher than 241.34% of that group.
  • To contextualize these metrics, consider that out of all US stocks, LEAP THERAPEUTICS INC's number of analysts covering the stock is greater than 344.51% of them.
  • In the context of stocks in the micro market cap category, LEAP THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 842.32% of them.
  • In terms of how LEAP THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -620.08% of that group.

Stocks similar to LEAP THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PULM, APVO, and NRBO.

Make investment decisions regarding LPTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!